Methyl 5-methoxybenzo[d]oxazole-2-carboxylate

Catalog No. :
ACTFZH723
CAS No. :
49559-57-1
Molecular Formula :
C10H9NO4
Molecular Weight :
207.18

IUPAC Name:methyl 5-methoxybenzo[d]oxazole-2-carboxylate

Methyl 5-methoxybenzo[d]oxazole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$70.00Login to see priceIn stockInquiry
1g98%$182.00Login to see priceIn stockInquiry
5g98%$595.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-methoxybenzo[d]oxazole-2-carboxylate
IUPAC Namemethyl 5-methoxybenzo[d]oxazole-2-carboxylate
MDL No.MFCD09701215
Molecular FormulaC10H9NO4
Molecular Weight207.18
SMILESCOC(=O)C1=NC2=CC(OC)=CC=C2O1
InChI KeyMGZDRAKFWQDAIR-UHFFFAOYSA-N
Synonym49559-57-1 | methyl 5-methoxybenzo[d]oxazole-2-carboxylate | 5-METHOXY-BENZOOXAZOLE-2-CARBOXYLIC ACID METHYL ESTER | METHYL 5-METHOXY-1,3-BENZOXAZOLE-2-CARBOXYLATE | MFCD09701215 | Methyl 5-Methoxybenzoxazole-2-carboxylate | DTXSID60538016 | ZBA55957 | AKOS016003805 | SB37
CAS No.49559-57-1
PubChem CID13353747

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACTFZH723 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTFZH723 route product structure diagram
    ACTFZH72349559-57-1 In Stock
Inquiry

2. ACTFZH723 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTFZH723 route product structure diagram
    ACTFZH72349559-57-1 In Stock
Inquiry

Comments (0)